Breast and ovarian cancer risks
Breast and ovarian cancer risks
Chemoprevention and breast cancer
Chemoprevention and ovarian cancer
Close surveillance for breast cancer
Primary
Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for
Ovarian Cancer Risk Reduction
Michael J. Callahan, Christopher P. Crum,
Fabiola Medeiros, David W. Kindelberger, Julia A. Elvin, Judy E. Garber,
Colleen M. Feltmate, Ross S. Berkowitz, Michael G. Muto. Journal
of Clinical Oncology. Volume 25, No. 25: p. 3985-3990, September 2007.
The
risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
Metcalfe
KA, Lynch HT, Ghadirian P, Tung N, Olivotto IA, Foulkes WD, Warner E, Olopade
O, Eisen A, Weber B, McLennan J, Sun P, Narod SA. Gynecologic
Oncology.
Volume 96, Issue 1, January 2005: p. 222-226. (Pubmed abstract)
Appropriateness
of breast-conserving treatment of breast carcinoma in women with germline
mutations in BRCA1 or BRCA2
Mark Robson, M.D., Tiffany Svahn, M.D.,
Beryl McCormick, M.D., Patrick Borgen, M.D., Clifford A.Hudis, M.D., Larry
Norton, M.D., Kenneth Offit, M.D., M.P.H. Cancer. Volume 103, Issue 1:
p. 44 - 51, January 2005.
Breast-feeding
and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Jernstrom,
H, Lubinski, J., Lynch, P., et al. Journal of
the National Cancer Institute.
Volume 96, No. 14, 1094-1098. July 21, 2004.
Contralateral breast
cancer in BRCA1 and BRCA2 mutation carriers
Kelly Metcalfe, Henry T.
Lynch, Parviz Ghadirian, Nadine Tung, Ivo Olivotto, Ellen Warner, Olufunmilayo
I. Olopade, Andrea Eisen, Barbara Weber, Jane McLennan, Ping Sun, William
D. Foulkes, Steven A. Narod. Journal of Clinical
Oncology. Volume 22, Number
12: p. 2328-2335, June 2004.
Smoking
and the risk of breast cancer among carriers of BRCA mutations
Parviz
Ghadirian, Jan Lubinski , Henry Lynch , Susan L. Neuhausen , Barbara Weber
, Claudine Isaacs , Ruth-Gershoni Baruch, Susan Randall, Peter Ainsworth,
Eitan Freidman, Douglas Horsman, Patricia Tonin, William D. Foulkes, Nadine
Tung, Ping Sun, Steven A. Narod. International
Journal of Cancer. Volume
110, Issue 3 , p. 413-416, June 2004.
Breast
and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
King
MC, Marks JH, Mandell JB; New York Breast Cancer Study Group. Science.
Volume 24, p. 643-6, October 2003. (Pubmed abstract)
BRCA1 and p53: Compensatory
roles in DNA repair
Anne-Renee Hartman and James M. Ford. Journal
of Molecular Medicine. September 9, 2003. (A literature review)
BRCA2 mutation
carriers, reproductive factors and breast cancer risk
Laufey Tryggvadottir,
Elinborg J Olafsdottir, Sigfridur Gudlaugsdottir, Steinunn Thorlacius,
Jon G Jonasson, Hrafn Tulinius and Jorunn E Eyfjord. Breast
Cancer Research.
Volume 5: p.121-128, June 2003.
Prevalence of BRCA1
and BRCA2 germline mutations in young breast cancer patients: A population-based
study
Silvia de Sanjosé, Mélanie Léoné,
Victoria Bérez, Angel Izquierdo, Rebeca Font, Joan M. Brunet, Thierry
Louat, Loreto Vilardell, Joan Borras, Pau Viladiu, F. Xavier Bosch, Gilbert
M. Lenoir, Olga M. Sinilnikova. International
Journal of Cancer. Volume
106, Number 4, p. 588-593, June 2003.
Reproductive
factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers
(United States)
Modugno F, Moslehi R, Ness RB, Nelson DB, Belle S,
Kant JA, Wheeler JE, Wonderlick A, Fishman D, Karlan B, Risch H, Cramer
DW, Dube MP, Narod SA. Cancer Causes Control. Volume 5: p. 439-46, June
2003. (Pubmed abstract)
Average
risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations
detected in case series unselected for family history: A combined analysis
of 22 studies
A. Antoniou, P. D. P. Pharoah, S. Narod, H. A. Risch,
J. E. Eyfjord, J. L. Hopper, N. Loman, H. Olsson, O. Johannsson, Å.
Borg, B. Pasini, P. Radice, S. Manoukian, D. M. Eccles, N. Tang, E. Olah,
H. Anton-Culver, E. Warner, J. Lubinski, J. Gronwald, B. Gorski, H. Tulinius,
S. Thorlacius, H. Eerola, H. Nevanlinna, K. Syrjäkoski, O.-P. Kallioniemi,
D. Thompson, C. Evans, J. Peto, F. Lalloo, D. G. Evans, and D. F. Easton.
American Journal of Human Genetics. Volume 72: p. 1117-1130, May 2003.
Ovarian
cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
Jaya
M. Satagopan, Jeff Boyd, Noah D. Kauff, Mark Robson, Lauren Scheuer, Steven
Narod and Kenneth Offit. Clinical Cancer Research. Volume 8: p. 3776-3781,
December 2002.
Cancer
risk estimates for BRCA1 mutation carriers identified in a risk evaluation
program
Marcia S. Brose, Timothy R. Rebbeck, Kathleen A. Calzone, Jill
E. Stopfer, Katherine L. Nathanson, Barbara L. Weber. Journal
of the National Cancer Institute. Volume 94, Number 18: p. 1365-1372, September 18, 2002.
On
the use of familial aggregation in population-based case probands for calculating
penetrance
Colin B. Begg. Journal of the National Cancer
Institute.
Vol. 94, Number 16: p. 1221-1226, August 21, 2002. (Note: a commentary on
this article is available in the same issue of JNCI.)
Clinical characteristics
of individuals with germline mutations in BRCA1 and BRCA2: Analysis of
10,000 individuals
Thomas S. Frank, Amie M. Deffenbaugh, Julia E. Reid,
Mark Hulick, Brian E. Ward, Beth Lingenfelter, Kathi L. Gumpper, Thomas
Scholl, Sean V. Tavtigian, Dmitry R. Pruss, Gregory C. Critchfield. Journal
of Clinical Oncology. Volume 20, Issue 6: p. 1480-1490, March 2002.
Modification
of BRCA1- and BRCA2: associated breast cancer risk by AIB1 genotypeand
reproductive history
Timothy R. Rebbeck, Yiting Wang, Philip W. Kantoff,
Krishna Krithivas, Susan L. Neuhausen, Andrew K. Godwin, Mary B. Daly,Steven
A. Narod, Jean-Sebastian Brunet, Daniel Vesprini, Judy E. Garber, Henry
T. Lynch, Barbara L. Weber and Myles Brown. Cancer
Research. Volume 61:
p. 5420-5424, July 2001.
The lifetime
risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2
mutations
Jaya M. Satagopan, Kenneth Offit, William Foulkes, Mark E.
Robson, Sholom Wacholder, Christine M. Eng, Stephen E. Karp and Colin B.
Begg. Cancer Epidemiology Biomarkers & Prevention. Volume 10: p. 467-473,
May 2001. (Full text)
Genetic
heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast
cancer families
D. Ford, D. F. Easton, M. Stratton, S. Narod, D. Goldgar,
P. Devilee, D. T. Bishop, B. Weber, G. Lenoir, J. Chang-Claude, H. Sobol,
M. D. Teare, J. Struewing, A. Arason, S. Scherneck, J. Peto, T. R. Rebbeck,
P. Tonin, S. Neuhausen, R. Barkardottir, J. Eyfjord, H. Lynch, B. A. J.
Ponder, S. A. Gayther, J. M. Birch, A. Lindblom, D. Stoppa-Lyonnet, Y.
Bignon, A. Borg, U. Hamann, N. Haites, R. J. Scott, C. M. Maugard, H. Vasen,
S. Seitz, L. A. Cannon-Albright, A. Schofield, M. Zelada-Hedman, and the
Breast Cancer Linkage Consortium. American Journal
of Human Genetics. Volume
62: p: 676-689, March 1998.
The
Risk of cancer associated with specific mutations of BRCA1 and BRCA2 among
Ashkenazi Jews
Jeffery P. Struewing, M.D., Patricia Hartge, Sc.D.,
Sholom Wacholder, Ph.D., Sonya M. Baker, B.S., Martha Berlin, B.A., Mary
McAdams, M.S., Michelle M. Timmerman, B.S., Lawrence C. Brody, Ph.D., and
Margaret A. Tucker, M.D. New England Journal
of Medicine. Volume 336, Number
20: p. 1401-1408, May 1997.
The
genetic attributable risk of breast and ovarian cancer
Claus EB, Schildkraut
JM, Thompson WD, Risch NJ. Cancer. Volume 77, Number 11: p. 2318-2324,
June 1996.